<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Health In Health Magazine &#187; Alzheimer&#8217;s Disease &amp; Memory</title>
	<atom:link href="http://www.healthinhealth.com/alzheimers-disease-memory/feed" rel="self" type="application/rss+xml" />
	<link>http://www.healthinhealth.com</link>
	<description>Health In Health - Free Health Guide</description>
	<lastBuildDate>Mon, 28 Sep 2009 05:13:30 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Treating Alzheimer&#8217;s Disease</title>
		<link>http://www.healthinhealth.com/alzheimers-disease-memory/treating-alzheimers-disease-75.html</link>
		<comments>http://www.healthinhealth.com/alzheimers-disease-memory/treating-alzheimers-disease-75.html#comments</comments>
		<pubDate>Sat, 15 Mar 2008 23:16:20 +0000</pubDate>
		<dc:creator>Health In Health</dc:creator>
				<category><![CDATA[Alzheimer's Disease & Memory]]></category>
		<category><![CDATA[Alzheimer’s Disease & Memory]]></category>
		<category><![CDATA[Treating Alzheimer's Disease]]></category>

		<guid isPermaLink="false">http://www.healthinhealth.com/alzheimers-disease-memory/treating-alzheimers-disease-75.html</guid>
		<description><![CDATA[Alzheimer&#8217;s disease is a progressive, irreversible brain disorder. Alzheimer&#8217;s disease (AD) is the most common form of dementia among older people. Alzheimer&#8217; destroys a person&#8217;s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account [...]]]></description>
			<content:encoded><![CDATA[<p>Alzheimer&#8217;s disease is a progressive, irreversible brain disorder. Alzheimer&#8217;s disease (AD) is the most common form of dementia among older people. Alzheimer&#8217; destroys a person&#8217;s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account for a much smaller number of cases of familial, early-onset AD. People with dementia often have trouble thinking and speaking clearly, remembering recent events, and learning new things. Over time, it becomes hard for them to handle everyday activities and take care of themselves. Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are associated with age-related (sporadic) AD. AD is part of an immune response that is attempting to contain the disease. The former may be more likely, since research indicates that anti-inflammatory drugs can prevent or retard AD development.</p>
<p>Alzheimer’s disease advances at widely different rates. Family history is another risk factor of Alzheimer&#8217;s. Several risk factor genes may interact with each other and with non-genetic factors to cause the disease. Cardiovascular Risk Factors The same factors that increase the risk for heart disease and stroke, such as high blood pressure, may also increase the risk for late-onset AD. Most people with mild forgetfulness do not have AD. In the early stage of AD, people may have trouble remembering recent events, activities, or the names of familiar people or things. Oxidative damage refers to cell damage caused by excess free radicals, which are highly reactive chemicals. Free radicals are often formed as a by-product of metabolism, or chemical processes within the cell. Excess free radicals may cause substantial neuronal damage, contributing to AD development. Type 2 Diabetes. A link between AD and type 2 diabetes, the form of diabetes in which insulin levels are high. One theory is that too much insulin in the blood promotes inflammation and oxidative damage in the brain, both of which contribute to AD development.</p>
<p>Symptoms of AD include memory loss, language deterioration, impaired ability to mentally manipulate visual information, poor judgment, confusion, restlessness, and mood swings. Alzheimer&#8217;s disease may also include behavioral changes, such as outbursts of violence or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and incontinence, will be seen if death from some external cause (e.g. heart attack or pneumonia) does not intervene. Moderate -As the disease progresses to the middle stage, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities. Severe — As the disease progresses from the middle to late stage, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.</p>
<p>Treatment Alzheimer&#8217;s Disease Tips</p>
<p>1. Acetylcholinesterase (AChE)-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons).</p>
<p>2. Ginkgo for the treatment of &#8220;cognitive impairment and dementia,&#8221; a Cochrane Review concludes that &#8220;there is promising evidence of improvement in cognition and function associated with Ginkgo According to this review the two randomized controlled studies that focused on Alzheimer&#8217;s patients both showed significant improvement in these areas.</p>
<p>3. Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques.</p>
<p>4. R-flurbiprofen (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.</p>
<p>5. Leuprolide has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.</p>
<p>6. Antihistamine drug Dimebon has also recently been found to show beneficial effects against Alzheimer&#8217;s disease in preliminary trials</p>
<p>7. Vaccines or immunotherapy for Alzheimer&#8217;s, unlike typical vaccines, would be used to treat diagnosed patients rather than for disease prevention.</p>
<p>8. Proposed alternative treatments for Alzheimer&#8217;s include a range of herbal compounds and dietary supplements.</p>
<p>9. Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatment, especially in the early to moderately advanced stages of disease.</p>
<p>10. DNA-based therapy is also  Treating Alzheimer&#8217;s Disease.</p>
<h2>About the Author</h2>
<p class="article_text"> Juliet Cohen writes articles for <a href="http://www.health-care-clinic.com/">health care clinic</a> and <a href="http://www.healingremedies.org/">home remedies</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthinhealth.com/alzheimers-disease-memory/treating-alzheimers-disease-75.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Progression of Alzheimer&#8217;s Disease</title>
		<link>http://www.healthinhealth.com/alzheimers-disease-memory/the-progression-of-alzheimers-disease-74.html</link>
		<comments>http://www.healthinhealth.com/alzheimers-disease-memory/the-progression-of-alzheimers-disease-74.html#comments</comments>
		<pubDate>Sat, 15 Mar 2008 23:15:13 +0000</pubDate>
		<dc:creator>Health In Health</dc:creator>
				<category><![CDATA[Alzheimer's Disease & Memory]]></category>
		<category><![CDATA[Alzheimer’s Disease & Memory]]></category>
		<category><![CDATA[Progression of Alzheimer's Disease]]></category>

		<guid isPermaLink="false">http://www.healthinhealth.com/alzheimers-disease-memory/the-progression-of-alzheimers-disease-74.html</guid>
		<description><![CDATA[Alzheimer’s disease is marked by slow development, and its characteristic decline in cognitive and behavioral function typically takes place gradually over a period of several years. It is because of this slow onset that many cases go undiagnosed until more severe symptoms become apparent. Over time, the disease affects a person’s memory, language skills, decision [...]]]></description>
			<content:encoded><![CDATA[<p>Alzheimer’s disease is marked by slow development, and its characteristic decline in cognitive and behavioral function typically takes place gradually over a period of several years. It is because of this slow onset that many cases go undiagnosed until more severe symptoms become apparent. Over time, the disease affects a person’s memory, language skills, decision making abilities and reasoning. Though the disease may be classified in individuals as mild, moderate or severe based on the extent of the symptoms, it is important to remember that each case is unique and progression will vary from one person to the next.</p>
<p>Although the stages of Alzheimer’s are not concrete time periods, knowing generally what to expect over time can be helpful in future care planning for anyone who has a loved one with Alzheimer’s disease. Here we examine some of the characteristic behaviors observed in the mild, moderate and severe stages of Alzheimer’s disease:</p>
<p>Mild/Early: In the early stages of Alzheimer’s disease, symptoms such as forgetfulness, a limited attention span and forgetting where things belong are often disregarded as typical signs of aging. Though some of the symptoms of early Alzheimer’s disease are similar to those experienced by a healthy person with age, a person with Alzheimer’s disease will exhibit such behaviors with more frequency and severity over time. A person in the mild stage of the disease may become less motivated, resist change and confuse one word with another when speaking. Often, the patient does not realize that he or she is experiencing these changes, and a close family member is the first to notice symptoms. People in the early stages of Alzheimer’s disease can usually remain at home, particularly when there is a spouse or other loved one there to help out.</p>
<p>Moderate/Middle: As the disease progresses into the moderate stage, symptoms become more severe, more recurrent and more apparent to other people as well as the patient. The middle stage of Alzheimer’s disease is marked by a decline in memory function, particularly short term memory, though a patient may retain his or her long term memory. Personality changes and an inability to make judgments are also extremely common in this stage. It is in the moderate stage that a person with Alzheimer’s may begin to have difficulty recognizing people they know, or confusing the identity of one person with another. People in this stage of Alzheimer’s do best having a caregiver available full time to help with daily needs and ensure their safety.</p>
<p>Severe/Advanced: Severe Alzheimer’s disease calls for fulltime care from a loved one or a professional caregiver. Patients at this stage have difficulty communicating and frequently do not recognize loved ones. Advanced Alzheimer’s disease causes patients to feel disoriented with their surroundings and exhibit severe mood swings.</p>
<p>Alzheimer’s disease affects every person differently, and all people with Alzheimer’s disease will not experience every described symptom. Though the disease is divided into stages to make understanding its progression easier, there is no set timeline for any one patient’s progression. Today, the progression of the Alzheimer’s symptoms can sometimes be delayed with medications and lifestyle changes.</p>
<h2>About the Author</h2>
<p class="article_text"> About the Author: John Trevey is the C.E.O. of Uncommon Care, a leading provider of <a href="http://www.uncommoncare.com/">Austin Alzheimer&#8217;s</a> care. He is the manager of both <a href="http://www.uncommoncare.com/">The Barton House</a> and the Breckinridge. For more information, please visit http://www.uncommoncare.com.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthinhealth.com/alzheimers-disease-memory/the-progression-of-alzheimers-disease-74.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
